The combined power of Caris’ DNA, RNA, and imaging data with COTA’s curated clinical data strengthens the offering to drive next-gen therapeutic development and advance patient care IRVING, Texas and NEW YORK, April 30, 2024 /PRNewswire/ — Caris Life Sciences®(Caris), the leading…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.